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ABSTRACT
Background
The objective of the study was to compare rates of adverse events (AEs) related to male
circumcision (MC) in HIV-positive and HIV-negative men in order to provide guidance for MC
programs that may provide services to HIV-infected and uninfected men.
Methods and Findings
A total of 2,326 HIV-negative and 420 HIV-positive men (World Health Organization [WHO]
stage I or II and CD4 counts . 350 cells/mm
3) were circumcised in two separate but
procedurally identical trials of MC for HIV and/or sexually transmitted infection prevention in
rural Rakai, Uganda. Participants were followed at 1–2 d and 5–9 d, and at 4–6 wk, to assess
surgery-related AEs, wound healing, and resumption of intercourse. AE risks and wound healing
were compared in HIV-positive and HIV-negative men. Adjusted odds ratios (AdjORs) were
estimated by multiple logistic regression, adjusting for baseline characteristics and post-
operative resumption of sex. At enrollment, HIV-positive men were older, more likely to be
married, reported more sexual partners, less condom use, and higher rates of sexually
transmitted disease symptoms than HIV-negative men. Risks of moderate or severe AEs were
3.1/100 and 3.5/100 in HIV-positive and HIV-negative participants, respectively (AdjOR 0.91,
95% confidence interval [CI] 0.47–1.74). Infections were the most common AEs (2.6/100 in HIV-
positive versus 3.0/100 in HIV-negative men). Risks of other complications were similar in the
two groups. The proportion with completed healing by 6 wk postsurgery was 92.7% in HIV-
positive men and 95.8% in HIV-negative men (p¼0.007). AEs were more common in men who
resumed intercourse before wound healing compared to those who waited (AdjOR 1.56, 95% CI
1.05–2.33).
Conclusions
Overall, the safety of MC was comparable in asymptomatic HIV-positive and HIV-negative
men, although healing was somewhat slower among the HIV infected. All men should be
strongly counseled to refrain from intercourse until full wound healing is achieved.
Trial registration: http://www.ClinicalTrials.gov; for HIV-negative men #NCT00425984 and
for HIV-positive men, #NCT00124878.
The Editors’ Summary of this article follows the references.
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Three randomized trials have shown that male circum-
cision (MC) reduces the risk of male HIV acquisition in men
by 50%–60% [1–3]. This ﬁnding suggests that the procedure
may be an important means of HIV prevention in areas where
circumcision is uncommon and where most HIV transmission
is due to heterosexual intercourse. The World Health
Organization (WHO) and Joint United Nations Programme
on HIV/AIDS (UNAIDS) has now recommended that MC be
promoted as an additional important strategy for preventing
heterosexual HIV infection in men [4]. The safety of surgery
is a paramount consideration in planning future circum-
cision programs, both to minimize surgical risks and to
provide guidelines for best practices in surgical procedures
and postoperative care. Although information is available on
postoperative complications in children and in HIV-negative
men [1–3,5–8], there is little information on the safety of
circumcision in HIV-infected men [3]; this presents an
important programmatic issue since future circumcision
services are likely to attract both HIV-infected and
-uninfected men. Moreover, WHO/UNAIDS guidelines rec-
ommend that circumcision be provided to HIV-positive men
if medically indicated or if they request the procedure. If
s u r g e r yw e r et ob eu n s a f ei nH I V - p o s i t i v em e n ,t h e s e
individuals might have to either be excluded from adult MC
programs, which would be potentially stigmatizing, or they
might require specialized services for postoperative care,
which could add to program costs and complexity.
We conducted two randomized trials of MC in rural Rakai
district of southwestern Uganda. One trial, supported by the
United States NIH, enrolled HIV-negative men [1]. This trial
was stopped for efﬁcacy on December 12, 2006. The other
trial, which was supported by the Bill & Melinda Gates
Foundation, enrolled HIV-positive men, and enrollment was
closed on December 19, 2006. In this paper we report on the
safety of circumcision in HIV-negative and HIV-positive men
enrolled into the intervention arms of these two trials.
Methods
The Rakai trials enrolled uncircumcised men aged 15–49 y
who provided informed consent for screening and for
randomization to immediate circumcision (the intervention
arm), or circumcision delayed for 24 m (the control arm). The
proﬁle of the two parallel trials is provided in Figure 1, and
details of trial design are reported elsewhere [1,9] and
described in Texts S1 and S2. In brief, 6,461 consenting
men were screened. If they were HIV-negative, had no
contraindications against or medical indications for surgery,
and accepted voluntary counseling and testing (VCT), they
were enrolled into an NIH-funded trial of HIV-negative men.
Men who were HIV-infected at screening, who did not have
symptoms of AIDS (WHO stages I or II) or CD4 count , 350
cells/mm
3, and who did not have contraindications to or
indications for MC, were offered VCT and were enrolled into
a Gates Foundation-funded trial. There were 540 screened
men who were ineligible for either trial or who failed to
complete enrollment and were excluded. The trials were
conducted in 50 rural communities of southwestern Uganda,
thus enrollment and follow-up were decentralized, but all
surgery took place in fully equipped outpatient theaters
located in a central facility.
In the NIH-supported trial, the primary end points were
safety and HIV acquisition. A total of 2,474 participants were
randomized to receive immediate circumcision. Of these,
2,328 (94.1%) received surgery within 6 m of enrollment,
which was completed in August 2005. Two seronegative men
who subsequently seroconverted were found to be PCR
Figure 1. Profile of Trials for HIV-Positive and HIV-Negative Participants
fu, follow up.
doi:10.1371/journal.pmed.0050116.g001
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excluded from the analysis, leaving 2,326 HIV-negative men
who received circumcision surgery. The Gates Foundation-
supported trial enrolled 925 HIV-positive men, and the
primary endpoints for male participants were safety and
sexually transmitted infection effects. Of these 925 HIV-
positive men, 474 were randomized to immediate circum-
cision and 420 (88.6%) had received surgery by December 19,
2006, when enrollment was closed. The Gates Foundation
trial Data Safety Monitoring Board (DSMB) closed enrollment
of HIV-positive men because the NIH trial was stopped for
efﬁcacy on December 12, 2006, and it was no longer feasible
to mask the HIV status of new HIV-positive participants,
(since HIV-negative men could no longer be randomized to
the control condition). At enrollment, 864/925 (93.4%) of
circumcised HIV-positive men accepted VCT.
Enrollment and follow-up procedures were identical for
HIV-positive and HIV-negative men. All men provided
written informed consent for screening and trial enrollment.
Men randomized to the intervention arm in either trial
provided written informed consent for surgery, which
described the procedure, risks of surgery, and the require-
ments for postoperative wound care (e.g., personal hygiene,
keeping the wound dry, and recognizing signs of complica-
tions), and they were strongly advised to refrain from sexual
intercourse until the wound was certiﬁed to be fully healed.
Men were also advised to practice safe sex, including as
appropriate sexual abstinence, monogamy with an uninfected
partner, and consistent condom use. Attempts were made to
contact spouses of male participants, and these female
partners were also instructed on wound care, the need for
sexual abstinence until wound healing was certiﬁed, and were
counseled on the subsequent practice of safe sex. Free
condoms were offered to all participants. Free individual
and couples counseling was also offered to all participants
and their spouses.
All participants had a medical examination, and any penile
pathology such as genital ulcerative disease (GUD), discharge,
or balanitis were treated prior to surgery. Circumcision was
performed by trained physicians in fully equipped outpatient
operating theaters. The physicians had completed an intern-
ship and were trained by the senior urologist (SW). Training
consisted of initially observing surgeries and conducting a
minimum of 15 supervised procedures prior to certiﬁcation
of competence. The sleeve circumcision procedure was used:
details of surgery are provided in the paper reporting the
results of the NIH-supported trial in HIV-negative men [1].
All men (HIV-positive or HIV-negative) received the same
surgical procedure and postoperative care. Postoperative
follow-up visits were scheduled at 24–48 h, 5–9 d, and 4–6 wk.
Men could access care at any time if complications occurred
between scheduled visits. Follow-up was conducted by health
workers (clinical ofﬁcers and nurses) who were trained to
diagnose and treat complications or to refer patients for
specialized care if needed. Visits took place at the surgical
center, in the participant’s home, or at central sites (‘‘hubs’’)
located in the rural communities. At each visit, a structured
history was taken to detect symptoms of complications, and
the wound was inspected. Wound healing was certiﬁed when
there was an intact healthy scar with no residual exudate or
scab formation, and all sutures had been completely
absorbed.
Surgery-related adverse events (AEs) were detected at
scheduled as well as at unscheduled postoperative visits.
Adverse events were predeﬁned and graded as mild,
moderate, and severe. (Protocol deﬁnitions are available on
request.) Grade 1 or mild AEs required no or minimal
treatment, whereas grade 2 (moderate) and grade 3 (severe
AEs) required medical or surgical intervention. Thus, the
moderate and severe AEs are most relevant to assessment of
safety. This report focuses on AEs classiﬁed as deﬁnitely,
probably, or possibly related to surgery. The relationship to
surgery was in most cases self evident (e.g., bleeding, wound
dehiscence, or infection), but in situations where the
relationship to surgery was unclear, we erred on the side of
caution and assumed a relationship existed. For example, one
severe AE requiring hospitalization involved acute severe
herpetic ulceration involving the penile shaft and scrotum,
but not the surgical wound. This episode occurred during the
postoperative period, and it was assumed that surgery
precipitated the reactivation of pre-existing herpes. The
anatomical site of any lesion was coded as involving the
frenulum or other areas of the penis, and codes were added
for AEs associated with external causes such as intercourse or
trauma.
All surgery-related AEs were reviewed by a medical ofﬁcer
at the time they were reported. The senior urologist (SW), the
NIH Medical Ofﬁcer (MCB), the trial Medical Ofﬁcer (GK),
and the principal investigator (RHG) each independently
reviewed all AEs. Subsequently, a panel of physicians, nurses,
and clinical ofﬁcers reviewed all cases and other available
records to establish a ﬁnal diagnosis, severity grading, and
assessment of relatedness to surgery. The panel’s ﬁnal
assignation was achieved by consensus.
Statistical Methods
Risks of surgery-related AEs were calculated as the number
of men with one or more AEs per 100 surgeries. We also
assessed multiple AEs experienced by individual participants
and tabulated diagnosis speciﬁc rates of AEs graded by
severity. Baseline characteristics were compared via chi-
squared tests of general association. In comparisons of two
proportions, p-values were calculated using chi-squared test
for equality of two proportions. Exact binomial conﬁdence
intervals (CIs) were calculated for risk estimates.
We compared surgery-related AE risks in HIV-positive and
HIV-negative men. We also assessed AE risks by sociodemo-
graphic characteristics (age, marital status, education, and
occupation), risk behaviors (number of sex partners, condom
use), and sexually transmitted disease symptoms (GUD,
dysuria, and urethral discharge), which differed in frequency
between HIV-positive and HIV-negative men at enrollment,
and thus potentially could confound the associations between
HIV status and the AE outcomes. Adjusted odds ratios
(AdjORs) and 95% CIs for all AEs and moderate and severe
AEs were estimated by multiple logistic regression. The
covariates included in adjusted analyses were age, marital
status, education, sex partners in the past year, condom use,
and sexually transmitted infection symptoms at enrollment,
and initiation of sex before certiﬁed wound healing.
We assessed the proportion of men who achieved certiﬁed
wound healing by 30 postoperative d and at 6 wk following
surgery, and evaluated surgery-related AEs among men who
reported intercourse prior to certiﬁed wound healing,
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Safety of Circumcisioncompared with men who resumed intercourse after healing
was certiﬁed or did not resume sexual activity. Analyses used
Intercooled Stata 8 and R.
These trials were reviewed and approved by two Institu-
tional Review Boards (IRBs) in Uganda (The Scientiﬁc and
Ethics Committee of the Uganda Virus Research Institute,
Entebbe, and the AIDS Subcommittee of the National
Council on Research and Technology, Kampala) and two
IRBs in the US (the Western Institutional Review Board,
Bloomberg School of Public Health, Olympia, Washington,
and the Johns Hopkins University, Institutional Review
Board, Baltimore, Maryland). Each trial was monitored by
separate independent DSMBs.
Results
Table 1 shows the characteristics of the circumcised HIV-
negative and HIV-positive men enrolled in the two trials. The
differences in baseline distributions of all these character-
istics were statistically signiﬁcant. The HIV-positive men were
substantially older than the HIV-negative men (median ages
32 versus 23 y, respectively), more likely to be married or
divorced/separated, and less likely to have secondary or
higher education. The HIV-infected men reported having
more sexual partners and being less likely to consistently use
condoms than the HIV-negative men. Moreover, the HIV-
infected men reported higher levels of genital ulceration,
urethral discharge, and dysuria.
The follow-up rates at the 4–6-wk postoperative visit were
93.6% for HIV-positive men (393/420) and 96.9% (2,253/2,326)
for HIV-negative men. Twenty-ﬁve (6.0%) of the HIV-positive
men experienced at least one AE, compared to 172 (7.4%) of
the HIV-negative men (Table 2, p ¼ 0.29). Only seven of the
HIV-positive men (1.7%) and 31 of the HIV-negative men
(1.3%) experienced more than one AE, and one HIV-negative
man had three AEs. The risks of moderate or severe (grades 2–
3) surgery-related AEs were 3.1/100 in the HIV-infected men
and 3.5/100 in HIV-negative men (p¼0.49). Risks of infections
were similar in the two groups, occurring in 2.6% of surgeries
in HIV-positive men and in 3.0% of surgeries in uninfected
men (p ¼ 0.70). Bleeding/hematoma complications were
comparable in HIV-positive (1.9%) and HIV-negative men
(2.4%, p¼0.56). Wound dehiscence was more common among
HIV-positive men (2.6%) compared to HIV-negative men
(1.3%), and this was statistically signiﬁcant (p ¼ 0.04). Other
individual AEs were infrequent, mostly mild, and were
comparable in both groups (e.g., pain 0.2% in HIV-positive
versus 0.3% in HIV-negative men, and difﬁculty voiding 0.2%
in HIV-positive versus 0.3% in HIV-negative participants).
We estimated the AdjORs of any AE and of moderate/
severe AEs by HIV status, controlling for characteristics and
behaviors found to differ signiﬁcantly between the two
groups at enrollment (Table 1), and for initiation of sex
before certiﬁcation of completed wound healing. The AdjOR
of any surgery-related AE in HIV-positive men relative to
HIV-negative men was 0.79 (95% CI 0.49–1.27), and the
AdjOR for moderate or severe AEs was 0.91 (95% CI 0.47–
1.74). GUD at enrollment was associated with an increased
rate of moderate or severe AEs (odds ratio ¼ 1.68, 95% CI
0.91–3.10, p¼0.095), despite the fact that GUDs were treated
prior to surgery. No other baseline covariates were found to
be associated with moderate/severe AEs.
The median time to wound healing could not be estimated
Table 1. Characteristics of HIV-Positive and HIV-Negative Men
Study Group Categories Characteristics, Behaviors,
and STI Symptoms
HIV-Positive Men HIV-Negative Men p-Value
a
n % n %
All 420 100.0 2,326 100.0 —
Age (y) 15–19 2 0.5 636 27.3 —
20–24 54 12.9 648 27.9 —
25–29 115 27.4 415 17.8 —
30–39 185 44.0 483 20.8 —
40–49 64 15.2 144 6.2 ,0.001
Marital status Currently married 291 69.3 1,100 47.3 —
Previously married 85 20.2 137 5.9 —
Never married 44 10.5 1,089 46.8 ,0.001
Education None 23 5.5 139 6.0 —
Primary 326 77.6 1,545 66.4 —
Secondary 51 12.1 550 23.6 —
Tertiary 20 4.8 92 4.0 ,0.001
Sex partners in past year (n) 0 31 7.4 442 19.0 —
1 187 44.5 1,079 46.4 —
2 119 28.3 514 22.1 —
3þ 83 19.8 291 12.5 ,0.001
Sexually Active Population 389 100 1,884 100 —
Condom use in past year Consistent 29 7.5 311 16.5 —
Inconsistent 177 45.5 654 34.7 —
None 183 47.0 919 48.8 ,0.001
STI symptoms in past year GUD 116 29.8 161 8.6 ,0.001
Urethral discharge 51 13.1 77 4.1 ,0.001
Dysuria 66 17.0 115 6.1 ,0.001
aChi-square tests of general association. STI, sexually transmitted infection.
doi:10.1371/journal.pmed.0050116.t001
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Safety of Circumcisionbecause men were observed at 1 wk and then again at 4–6 wk
or thereafter, and completed healing had to precede the
scheduled visit at which time the wound was observed and
certiﬁed. However, follow-up by 30 d postoperatively was
available for 393 out of 420 HIV-positive men (93.6%), and
2,258 out of 2,326 HIV-negative men (97.1%). By 30 d
following surgery, completed wound healing was certiﬁed in
73.0% (287/393) of HIV-positive men, compared with 83.2%
(1,879/2,258) of HIV-negative men (p , 0.001), suggesting
more rapid wound healing in the HIV-uninfected partic-
ipants. Men who were not completely healed at 4–6 wk were
followed weekly until healing was complete. At 6 wk after
surgery, 92.7% (364/393) of HIV-positive and 95.8% (2,163/
2,258) of HIV-negative men had complete wound healing
certiﬁed (p ¼ 0.007).
The risks of surgery-related AEs by self-reported timing of
intercourse relative to certiﬁcation of wound healing were
assessed (Table 3). We classiﬁed participants as men who
initiated intercourse early (  5 d before certiﬁcation of
wound healing), and men who either initiated sex within 5 d
of certiﬁcation or after healing was complete. Among the
HIV-positive circumcised participants, 66 (15.7%) reported
that they had resumed sex before the wound was certiﬁed as
healed, whereas among HIV-negative circumcised men, 250
(10.7%) reported resumption of sex before certiﬁcation of
healing. This difference was statistically signiﬁcant (p¼0.003).
A higher proportion of HIV-positive men were married, and
married men were more likely to resume sex prior to healing
certiﬁcation than were unmarried men. Among 266 HIV-
positive currently married men with follow-up information,
74 (27.8%) reported resuming intercourse before wound
healing, whereas among 116 HIV-positive unmarried men, 16
(13.8%) resumed sex before healing was certiﬁed (p ¼ 0.003).
Similarly, among 1,047 currently married HIV-negative men,
305 (29.1%) reported resumption of sex before healing,
compared to 75 (6.3%) out of 1,182 unmarried men (p ,
0.001). Early resumption of intercourse was associated with an
increased risk of all surgery-related AEs in HIV-negative and
HIV-positive men, although this was statistically signiﬁcant
only for the HIV-uninfected. Early resumption of intercourse
prior to wound healing is of programmatic concern because
HIV-infected men who resumed sex before wound healing
Table 2. Surgery-Related AEs by Severity
AEs Category AE Grades HIV-Positive (n ¼ 420 Men) HIV-Negative (n ¼ 2,326 Men)
Number of Men
with AEs
Percentage
(95% CI)
Number of Men
with AEs
Percentage
(95% CI)
p-Value
a
AEs related to surgery 1 12 2.9 90 3.9 —
2 13 3.1 77 3.3 —
3 0 0.0 5 0.2 —
Total AEs 25 6.0 (3.9–8.7) 172 7.4 (6.4–8.5) 0.29
Common cause-specific AEs Infection 1 3 0.7 16 0.7 —
2 8 1.9 52 2.2 —
3 0 0.0 1 0.04 —
All infections 11 2.6 (1.3–4.6) 69 3.0 (2.3–3.7) 0.70
Bleeding/hematoma 1 3 0.7 31 1.3 —
2 5 1.2 22 9.5 —
3 0 0.0 2 0.1 —
All bleeding/hematoma 8 1.9 (0.8–3.7) 55 2.4 (1.8–3.1) 0.56
Wound dehiscence 1 11 2.6 27 1.2 —
2 0 0.0 2 0.1 —
3 0 0.0 1 0.04 —
All dehiscence 11 2.6 (1.3–4.6) 30 1.3 (0.9–1.8) 0.04
aChi-square tests for comparison of two proportions.
doi:10.1371/journal.pmed.0050116.t002
Table 3. Risks of Surgery-Related AEs by Timing of Resumption of Intercourse in HIV-Positive and HIV-Negative Men
Risks of Surgery-
Related AEs
Resumption of
Intercourse
before Healing
HIV-Positive HIV-Negative All Men
AEs n % RR (95% CI) AEs n % RR (95% CI) AEs n % RR (95% CI)
All AEs Yes 6 66 9.1 1.63 (0.68–3.93) 29 250 11.6 1.67 (1.14–2.43) 35 316 11.1 1.64 (1.16–2.32)
No 19 341 5.6 1.00 143 2,056 7.0 1.00 162 2,397 6.8 1.00
Grade 2 and 3 AEs Yes 2 66 3.0 0.94 (0.21–4.14) 8 250 3.2 0.89 (0.43–1.82) 10 316 3.2 0.89 (0.49–1.70)
No 11 341 3.2 1.00 74 2,056 3.6 1.00 85 2,397 3.5 1.00
Grade 2 and 3 infections Yes 2 66 3.0 1.72 (0.36–8.35) 7 250 2.8 1.25 (0.57–2.74) 9 316 2.8 1.31 (0.65–2.64)
No 6 341 1.8 1.00 46 2,056 2.2 1.00 52 2,397 2.2 1.00
Unadjusted risk ratios (RRs) are presented. AdjORs estimated by multiple logistic regression are given in the text.
doi:10.1371/journal.pmed.0050116.t003
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Safety of Circumcisionwere more likely to infect their female partners (see
Discussion) [9], so we assessed the frequency of AEs for both
groups combined. The AdjOR of any AE associated with
resumption of sex before certiﬁed wound healing was 1.56
(95% CI 1.05–2.34, p ¼ 0.029). However, early resumption of
intercourse was not associated with increased moderate or
severe AEs (AdjOR ¼ 0.83, 95% CI 0.42–1.63).
We assessed condom use after resumption of sex at an
interview 6 mo postenrollment. Among 314 sexually active
HIV-positive participants, 53 (16.9%) reported consistent
condom use during follow-up compared with 1,755 sexually
active HIV-negative men, of whom 330 (18.8%) reported
consistent condom use (p ¼ 0.42). However, postoperative
consistent condom use by the HIV-positive participants
during follow-up increased relative to use at enrollment
(16.9% versus 7.7%, respectively, p , 0.001). Among HIV-
positive men, 45.2% reported inconsistent condom use
compared with 37.0% of HIV-negative men (p ¼ 0.006).
Discussion
We found that the risks of moderate or severe AEs
following adult MC were 3.1% in HIV-infected and 3.5% in
HIV-negative men. Thus, we conclude that circumcision
performed by adequately trained and equipped medical
personnel is likely to be safe in HIV-infected men with
WHO stage I or II disease and with a CD4 count . 350 cells/
mm
3. Completed wound healing was more rapid in the HIV-
negative than in the HIV-positive men, but over 90% of
wounds were certiﬁed as completely healed by 6 wk post-
operatively. Resumption of intercourse before wound healing
was associated with higher rates of surgical complications;
thus both circumcised men and their partners should be
strongly counseled to delay intercourse until full wound
healing is achieved.
It is difﬁcult to compare complication rates following adult
MC between the three trials of circumcision for HIV
prevention [1–3] or case series [7,8] because of differences
in AE deﬁnitions, and in methods used for detection of AEs
and for reporting of events. Further, with the exception of
the three HIV prevention trials reported to date [1–3], adult
MC is usually performed for medical indications, and the
underlying medical conditions (e.g., balanitis, phimosis,
ulceration) may contribute to postoperative morbidity. Adult
MC complication rates reported in the literature range from
2% to 10% in HIV-negative men [8]. Thus, the complication
rates observed in the Rakai trial are compatible with rates
associated with circumcisions performed by medically trained
practitioners elsewhere. Among HIV-negative men, the rates
of surgery-related AEs were 1.7% in the Kenyan trial [2]
(although an earlier publication reported a rate of 3.5% [7]),
and 3.6% in the South African trial [3]. These rates are
compatible with moderate and severe events observed in the
present study, but lower than the total AEs observed here
(Table 2). However, differences in methods of ascertainment
and diagnosis make strict comparisons of AEs between these
trials problematic. For example, in the present study in a
rural area, AEs were detected by clinical ofﬁcers mainly
during ﬁeld visits. Review of the AEs suggested that the
clinical ofﬁcers were concerned about access to health
services in this setting and tended to overtreat and possibly
overdiagnose minor complications. In the South African and
Kenyan trials ascertainment of AEs occurred in a central
clinic and in settings with better access to services. Thus, the
context of the study may have affected reporting. There is
little experience with circumcision in HIV-positive adults.
The circumcision trial in South Africa reported a surgery-
related AE rate of 8.2% in 73 HIV-infected men [3], which is
similar to the total AE rate of 6.0% observed in the present
trial (Table 2).
The risks of complications following circumcision observed
in this and other trials represent the ‘‘best case’’ for safe
surgery and were lower than rates of surgical complications
observed in public hospitals (11.1%), private medical facilities
(22.5%), and traditional practitioners (34.3%) in Kenya [9,10–
12]. High complication rates and deaths have been reported
with traditional pubertal circumcision in South Africa [13].
Thus, in the scale-up of circumcision programs it will be
imperative to provide services under the best feasible
circumstances and to upgrade existing personnel and
facilities. Efforts will also be required to minimize surgeries
by traditional practitioners or to ensure that they have
requisite skills.
There is limited experience with the widespread use of
surgery as a public health intervention. Mass sterilization
programs in India during the 1970s reported serious
complications and deaths due to inadequate attention to
surgical quality, asepsis, and postoperative care. This led to
wide-scale social protest and ultimately rejection of the
program [14,15]. Thus, when circumcision is adopted for HIV
prevention, it will be imperative to provide safe surgery and
good postoperative care, and to mitigate the possible harm
that could arise if traditional procedures are promoted, or if
inexperienced medical personnel perform the operation
under less than optimal circumstances. Future studies are
needed in nonresearch settings to determine the safety of
circumcision in programs.
Our ﬁnding that complications of circumcision are similar
in HIV-positive and HIV-negative men has important
programmatic implications. Inclusion of HIV-positive men
in future circumcision programs could avoid potential
stigmatization and may be of beneﬁt to these men by
reducing GUD [9]. Although the addition of VCT to circum-
cision programs is highly desirable, under WHO/UNAIDS
guidelines it would not have to be a mandatory precondition
for provision of safe surgery [4], and this could reduce
barriers for persons unwilling to be tested for HIV, as well as
reduce the costs and complexity of circumcision services. An
additional ﬁnding of programmatic relevance is that re-
sumption of sex before completed wound healing was
associated with increased AEs, and that wound healing was
complete for more than 90% of participants by 6 wk
postoperatively. Also, in a separate analysis of male-to-female
HIV transmission following circumcision in the Rakai trial,
HIV-infected men who resumed intercourse before certiﬁed
wound healing were more likely to transmit HIV to their
initially uninfected female partners [9]. This suggests that, if
follow-up to certify wound healing cannot be conducted, it
would be prudent for programs to recommend sexual
abstinence for a minimum of 6 wk after surgery both to
avoid complications of surgery and to minimize risks to
female partners.
In summary, our ﬁndings suggest that circumcision is as
safe in HIV-infected men with WHO stage I or II or CD4
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3, as in uninfected men, and the rates
of moderate or severe AEs are acceptably low. However,
healing was slower among HIV-positive men, and resumption
of intercourse before full wound healing was associated with
higher complication rates, irrespective of HIV status, so there
is a need to strongly advise men and their female partners of
the necessity to abstain from sex until full wound healing is
achieved.
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Safety of CircumcisionEditors’ Summary
Background Worldwide over 33 million people are thought to be living
with HIV, and in the absence of a vaccine, preventing its spread is a
major health issue. The World Health Organization (WHO) and the Joint
United Nations Programme on HIV/AIDS (UNAIDS) estimate that 68% of
2.5 million new infections worldwide in 2007 took place in sub-Saharan
Africa, where 76% of 2.1 million AIDS-related deaths also took place.
One of the principal means of person-to-person transmission of HIV is
through sex without the protection of a condom. In parts of Africa, male
circumcision is performed in infancy or childhood for religious or cultural
reasons or is a traditional rite of passage that marks the transition from
child to man. Three trials, in South Africa, Kenya, and Uganda, each found
that circumcised men were around half as likely as uncircumcised men to
contract HIV from HIV-positive female partners. After reviewing the
results, WHO and UNAIDS issued joint advice that male circumcision
should be promoted for preventing HIV infection in heterosexual men.
As male circumcision does not provide complete protection against HIV
infection, they advised that it should be promoted in addition to existing
strategies of promoting condom use, abstinence, and a reduction in the
number of sexual partners.
Why Was This Study Done? Although earlier studies had shown that
adult male circumcision, when performed in Africa under optimal
conditions, is a safe procedure for HIV-negative men, it was not known
whether it would also be a safe procedure for HIV-positive men. WHO
guidelines recommend that HIV-positive men who request the
procedure or have a medical need and no contraindications for it
should be circumcised. Also, exclusion of HIV-positive men from
circumcision programs may result in stigmatization of these men, and
discourage participation by men who do not wish to be tested for HIV.
Therefore, it is important to know whether the procedure is safe for HIV-
positive men.
What Did the Researchers Do and Find? The authors compared results
from two separate clinical trials carried out with identical procedures in
rural Rakai, Uganda. The first, which compared the effect of circumcision
with no circumcision in HIV-negative men, was one of the three trials
that persuaded the WHO and UNAIDS to promote male circumcision as
an HIV prevention strategy. The second Rakai trial did the same
comparison but in men who were HIV positive and without symptoms. In
this present study, the authors used data from both trials to compare the
likelihood of surgery-related complications following circumcision for
HIV-negative and HIV-positive men.
The trials recruited men aged 15–49, who were randomly assigned to be
circumcised either on enrollment or two years later and were followed
up to monitor complications related to the procedure, such as infections,
as well as wound healing and when the participant first had sex after the
operation. Condom use was recorded at enrollment and six months after
enrollment.
The researchers found that most complications were infrequent, mild,
and comparable in both groups, with moderate-to-severe complications
occurring in only 3%–4% of men in each group. However, delayed
wound healing was more frequent in HIV-positive men. Complications
were more likely among men who had sex before healing was complete;
such men were more likely to be HIV-positive and/or married. Similarly,
moderate or severe complications were more likely where men had
symptoms of sexually transmitted disease at enrollment, although these
were treated before surgery, and these men were more likely to be HIV-
positive. Six months after enrollment, similar proportions of HIV-positive
and HIV-negative men used condoms consistently, but HIV-positive men
were more likely to report using condoms inconsistently than HIV-
negative men. However, consistent use of a condom increased among
the HIV-positive men compared to when they enrolled.
What Do these Findings Mean? Circumcision in HIV-positive men
without symptoms of AIDS has a low rate of complications, although
healing is slower than in HIV-negative men. Because of the greater risk of
complications if sex is resumed before full healing, both men and their
women partners should be advised to have no sex for at least six weeks
after the operation. A separately reported analysis from one of these
studies found that women partners are more likely to become HIV
infected by HIV-positive men who resume sex prior to complete wound
healing. Therefore, for protection of both men and their female partners,
it is essential to refrain from intercourse after circumcision until the
wound has completely healed.
Because the study found no increased risk of surgical complications in
HIV-positive men who undergo circumcision, it should not be necessary
to screen men with no symptoms of HIV in future circumcision programs.
This should reduce the complexity of implementing such programs and
reduce any stigma resulting from exclusion, making it likely that more
men will be willing to be circumcised. The rise in consistent condom use
among HIV-positive men suggests that messages of safe sex are reaching
an important target group and changing their behavior, and that
circumcision does not make men less likely to use a condom.
The authors also noted that the rates of complications they observed
were low compared with those following traditional circumcision
procedures. Others have found that circumcision carried out under
unsafe conditions has a high rate of complications. The authors of this
study comment that the resources and standards of surgery during the
trial represented best practice and that to attain similarly low rates of
complications—and the confidence of men in the safety of the
procedure—there is a need to ensure sufficient resources and high
standards of training.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050116.
  WHO and the UNAIDS issued a joint report recommending male
circumcision for HIV prevention and another on the HIV epidemic
worldwide in December 2007
  An information pack here on male circumcision and HIV prevention
has also been developed jointly by WHO/UNAIDS, the United Nations
International Children’s Emergency Fund (UNICEF), the United Nations
Population Fund (UNFPA), and the World Bank
  The University of California San Francisco’s HIV InSite provides
information on HIV prevention, treatment, and policy
  AEGIS is the world’s largest searchable database on HIV and AIDS
  The National AIDS Trust provides information on HIV prevention
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